) discussed the use of mixture experiment design and modeling methods to study how the proportions of three components in an extemporaneous oral suspension affected the mean diameter of drug particles (Z ave ). The three components were itraconazole (ITZ), Tween 20 (TW20), and Methocel® E5 (E5). This commentary addresses some errors and other issues in the previous paper, and also discusses an improved model relating proportions of ITZ, TW20, and E5 to Z ave . The improved model contains six of the 10 terms in the full-cubic mixture model, which were selected using a different cross-validation procedure than used in the previous paper. Compared to the four-term model presented in the previous paper, the improved model fit the data better, had excellent cross-validation performance, and the predicted Z ave of a validation point was within model uncertainty of the measured value.
Introduction
A previous paper (Foglio Bonda et al., 2016 discussed the results obtained applying mixture experiment design and modeling methods to study an extemporaneous drug nanosuspension constituted of itraconazole (ITZ) as the drug and Tween 20 (TW20) and Methocel® E5 (E5) as stabilizing agents. The extemporaneous nanosuspension was prepared by a high-pressure homogenization treatment of a ITZ and TW20 aqueous dispersion, and then adding the cellulose polymer E5. This was followed by spray drying of the obtained nanodispersion.
One of the aims of FB2016 was to investigate how the proportions of the components ITZ, TW20, and E5 affected the mean diameter of drug particles (Z ave ) in the reconstituted nanosuspension. To attain this goal, FB2016 used a mixture experiment design requiring 10 experiments (Table 1 ). The mixture experiment design was chosen to explore the composition region specified by the mass-fraction constraints 0.6600 ≤ ITZ ≤ 0.8600, 0.0600 ≤ TW20 ≤ 0.1600, and 0.0570 ≤ E5 ≤ 0.2800. In Section 2.7 of FB2016, the lower bound of E5 was mistakenly listed as 6% instead of 5.7%. Because of the complexity of the process for producing nanosuspensions, several replicates of each design point were conducted (Table 2) .
After the publication of FB2016, the second author of this commentary (not an author of FB2016) contacted the corresponding author to point out some errors as well as insufficient explanations in parts of FB2016. This commentary addresses these issues and presents the results of re-analyzing the experimental data to improve the model relating the component proportions to the size of the drug particles. Table 1 (a slight revision of Table 2 in FB2016) lists the mass fractions of the three components for the 10 mixture design formulations. Table 1 lists the component mass fractions to four decimal places rather than the three decimal places in Table 2 of FB2016, to accurately document the mixtures investigated and so that the mass fractions for each mixture sum exactly to unity.
Methods
It is common in designing and modeling the results of mixture experiments to use L-pseudocomponents on a reduced simplex instead of the original components on the complete simplex (Cornell, 2002) . The L-pseudocomponent proportions (Cornell, 2002) were calculated using the equation
′ is the proportion of the i th L-pseudocomponent, x i is the proportion of the i th component, L i is the lower bound of proportions for the i th component, and q is the number of components (three in the present case). The proportions of the L-pseudocomponents for the mixture design formulations are also listed in Table 1 , and were used throughout the work. sively leaves out all replicates of each distinct design point when fitting the model to assess the model predictive ability for the left-out distinct design point), and RMSE (root mean squared error). Also included is the p-value associated with the model lack-of-fit test performed using the replicate tests to estimate "pure error" (Cornell, 2002) .
Results
In FB2016, the experimental data in Tables 1 and 2 were statistically analysed using a variable-selection procedure to retain only the most significant of the terms in the special-cubic mixture (SCM) model (Cornell, 2002) given by ( 1) A common log (base 10) transformation of the Z ave values was used to satisfy the assumption of ordinary least squares regression that the experimental errors have a common variance (homoscedasticity). Moreover, the log transformation is often used to describe the dimension and distribution of particle size in the micro-and nano-metric ranges and for modeling.
Values of log 10 (Z ave ) rounded to three decimal places were used for the model development work in FB2016, with the results reported in their Table 5 . Some of the model fit statistics reported in that table were incorrectly calculated. The usual formulas used to calculate these statistics for a model with no intercept term are incorrect for mixture experiment models (Cornell, 2002; Marquardt and Snee, 1974) . Also, regression diagnostics indicated that a replicate (the Z ave = 1990 value for the second batch of r-NS Exp. Point 7) was a possible outlier. Hence, for this commentary, the four-term model from Table 5 of FB2016 was refitted with and without the possible outlier, unrounded log 10 (Z ave ) values were used, and the model fit statistics were correctly calculated. The results with the outlier are 
while the results without the outlier are 
Hence, the four-term reduced SCM models in Eqs. (2) and (3) do not fit the data as well as was indicated in Table 5 of FB2016 because of the miscalculated fit statistics listed there.
As part of the work for this commentary, an improved model was developed. The experimental data (without the possible outlier and without rounding the log 10 (Z ave ) values) were fit to the Scheffé fullcubic mixture (FCM) model (Cornell, 2002) and to a series of reduced models derived from it. The FCM model was chosen as a starting point for developing an improved model because it can accommodate more complicated blending effects of the components on a response variable than the SCM model (Cornell, 2002) . In FB2016, a leave-one-out cross validation (CV) approach was used to select the reduced SCM model as giving the best approximation of the relationship between log 10 (Z ave ) and the proportions of the L-pseudocomponents. (Although R P 2 is the usual notation used for the leave-oneout CV approach, in FB2016 the R CV 2 notation was used instead of R P 2 .)
Because there were replicates (multiple batches) for each mixture formulation (see Table 2 ), a different CV approach was employed for the results in this commentary. Specifically, all of the replicates of a given design point were excluded when that point was (in turn) left out in computing the fitted models. This CV approach avoids the problem of multiple outliers for a given design point. The R 2 statistic calculated with this CV approach is here denoted R CV 2 , as discussed in Section 2.
However, this CV approach to selecting a final model form may have been overly conservative, given that the full and reduced FCM models considered have four to 10 terms and the mixture experimental design (see Table 2 ) contained only 10 distinct formulations. Having only a few more distinct design formulations than model terms can make some distinct design formulations very influential in fitting models. The data of Table 2 were first fit to a FCM model using an ordinary least squares regression method. The regression diagnostics for this model again identified the same replicate as a potential outlier (the Z ave = 1990 value of the second batch of r-NS Exp. Point 7). This replicate was excluded and the remaining 37 data points were used in subsequent fittings of the FCM model and reduced versions thereof. The CV method previously described was employed, with R CV 2 used to rank the various fitted reduced FCM models. Table 3 contains the coefficient estimates and fit statistics for the two best reduced FCM models obtained (Model A and Model B). The R 2 and R Adj 2 statistics are high (> 0.946) for both models, with Model B having slightly higher values. Both models had statistically significant lack-of-fits (p < 0.002), but these were judged as not of practical concern for this work. The predictive ability of Model A was better than that of Model B, as evidenced by the R CV 2 values 0.8281 and 0.7399, respectively. The values of this statistic, while possibly being overly conservative, suggest Model A as the best in approximating the relationship between the component proportions and the particle size of the reconstituted nanosuspension. Model A (Table 3 ) was used to predict Z ave for an extemporaneous nanosuspension of 0.6870 ITZ, 0.1330 TW20, and 0.1800 E5, taken as a validation point (VP), as shown in Fig. 1 . The calculated particle size was 417.5 nm, with a 95% prediction interval of (343.6, 507.2). This prediction interval contains the measured particle size for this mixture (434.1 ± 25.5 nm), indicating the measured value is within the model's prediction uncertainty. Note that the 95% prediction interval was calculated in log 10 (Z ave ) units, and then transformed back into the original units. Fig. 1 shows the contour plot for predicted values of Z ave , based on Model A in Table 3 as a function of the proportions of the original three components (ITZ, TW20, E5). Fig. 2 illustrates the predicted effects on Z ave of each component along the Cox effect directions (Cornell, 2002) . In Figs. 1 and 2 , for increased interpretability, the original components were used instead of the L-pseudocomponents, and predicted values of log 10 (Z ave ) were transformed back to predicted Z ave values. Fig. 2 shows that ITZ is predicted to have (i) a negligible effect on the mean diameter of particles (Z ave ) for ITZ less than approximately 0.70, and (ii) an increasing effect above that proportion. As for the effect of E5, Z ave is predicted to decrease with increasing proportions of the stabilizing agent up to a proportion of approximately 0.20. Increasing E5 above that proportion then predicts increasing values of Z ave . Finally, TW20 is predicted to not have a strong effect on Z ave .
Discussion
The mixture design and dataset listed in Tables 1 and 2 The results of the new modeling work in this commentary indicate that the relationship between the size of nanoparticles and the proportions of the components in the reconstituted nanosuspension can be better predicted by the six-term reduced FCM model than by the fourterm reduced SCM model from FB2016. The six-term reduced FCM F. Pattarino et al. European Journal of Pharmaceutical Sciences 117 (2018) 297-300 model for the data without the outlier has R 2 = 0.9537, R Adj 2 = 0.9462, and R CV 2 = 0.8281 values. These values are higher than the R 2 = 0.8804, R Adj 2 = 0.8695, and R CV 2 = 0.7240 corrected values for the four-term reduced SCM model from FB2016. This finding leads to the conclusion that the choice of the regression model fit to the dataset coming from a mixture experiment design is crucial in order to obtain the most accurate and precise predictions of the mixture properties. Finally, a reviewer of this commentary noted that a simpler data analysis approach without modeling could have been used. Considering the data in Table 2 and the formulation compositions in Table 1 , the reviewer observed that E5 > 0.08 appears critical for obtaining a nanosuspension. The reviewer also noted that no lowest possible concentration of TW20 was apparent from the data, but with further experimentation the formulator could try to lower the TW20 concentration in order to reduce the risk for Ostwald ripening. We agree with the reviewer that a researcher should first simply analyze the experimental data, considering previous knowledge and experience. However, modeling experimental data (developed according to a statistically designed experiment) and considering plots like Figs. 1 and 2 produced using a fitted mixture experiment model can provide further insight that is useful for understanding component effects and developing formulations with desirable properties. Also, models can be used to predict property values and their uncertainties for formulations that have not been experimentally tested.
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